99mTc-Duramycin

N/A

Report date: 2025/11/20 16:00:53

NME

Base Information

Drug Name99mTc-Duramycin

Drug Alias NameTc-99m-duramycinTDURATechnetium 99m duramycinTechnetium duramycin99mTc-Duramycin

ClassificationRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Technetium > 99mTc +[5]

Mechanisms of ActionRadionuclide imaging enhancersChloride channel agonistsCytosolic phospholipase A2 inhibitors

TargetsChloride channelCytosolic phospholipase A2

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesThe Medical College Of Wisconsin Nonprofit

China Registration ClassN/A

Develop Information

Active CompaniesMolecular Targeting Technologies Inc

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A